StockData
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30
$0.54+0.04 (+8.49%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

IM Cannabis net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -C$11.32M. The highest annual figure on record is -C$7.29M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-C$11.32M–
FY2024Dec 31, 2024-C$10.59M–
FY2023Dec 31, 2023-C$9.50M–
FY2022Dec 31, 2022-C$188.89M–
FY2021Dec 31, 2021-C$17.76M–
FY2020Dec 31, 2020-C$28.70M–
FY2019Dec 31, 2019-C$7.29M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-C$4.36M–
Q2 FY2025Jun 30, 2025-C$309.00K–
Q2 FY2024Jun 30, 2024-C$3.03M–
Q2 FY2023Jun 30, 2023-C$3.46M–
Q2 FY2022Jun 30, 2022-C$18.67M–
Q2 FY2021Jun 30, 2021-C$4.63M–

More IM Cannabis figures

See a number that looks wrong?